History repeats itself: horse originated hyperimmune sera production against SARS CoV-2

Ahu Pakdemirli Elvin Çalişkan Sabri Hacioğlu Erdem Danyer Özlem Kardoğan Züleyha Ergün Kurt Özcan Yildirim Hakan Taşkaya Bora Ündar Yasemin Sezgin Gencay Ergin Himmet Ekici Ufuk Ülker Erkan Taçbaş Şahin Çakir Ramazan Bülbül Mustafa Bebek Meral Sarper Dilek Dülger Ümmü Sena Sari Fatma Ergin Özden Kabakli Cevdet Yarali

Published in: Turkish journal of medical sciences (2021)

This study presents a profitable practice to develop specific antisera in horses against SARS-CoV-2 for emergency and low-cost response. In further studies, new purification methods can be used to increase the efficiency of the final product.

Keyphrases

sars cov
low cost
respiratory syndrome coronavirus
healthcare
emergency department
primary care
coronavirus disease
recombinant human